跳轉至內容
Merck
  • Potentially simple score of late gadolinium enhancement cardiac MR in acute myocarditis outcome.

Potentially simple score of late gadolinium enhancement cardiac MR in acute myocarditis outcome.

Journal of magnetic resonance imaging : JMRI (2013-12-03)
Gilles Barone-Rochette, Caroline Augier, Mathieu Rodière, Jean-Louis Quesada, Alison Foote, Hélène Bouvaist, Stéphanie Marlière, Daniel Fagret, Jean Philippe Baguet, Gérald Vanzetto
摘要

To determine the value of cardiac MRI for the monitoring and the prognosis of patients with acute myocarditis. Cardiac MRI plays an increasingly important role in the diagnosis of acute myocarditis. However, it is less established as a prognostic tool, which requires specific postprocessing of images. In a prospective pilot study, we assessed the prognostic value of the evolution in a simplified visual quantitative score (SQS) of late gadolinium enhancement (LGE) between initial hospitalization and 3 months later. The prognostic value was assessed at 1 year using a combination of death, heart transplant, and confirmed recurrence as main outcome. Twenty-eight patients were included in this study. A significant correlation was found between LGE measured by SQS and planimetry (r = 0.95, P < 0.001). Intraobserver and interobserver reproducibilities were good for SQS (ICC = 0.95 [95% CI: 0.86 to 0.98], and 0.94 [95% CI: 0.84 to 0.98], respectively). At initial hospitalization, patient characteristics between the two groups were similar. Patients with stable or increased SQS suffered more frequently from clinical outcome events than patients with a decrease in SQS (P = 0.02). Monitoring of the evolution of LGE using a simple visual score is of interest to identify patients at risk of pejorative prognosis after acute myocarditis.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
N -甲基- D -葡胺, 99.0-100.5% (titration)
Sigma-Aldrich
N -甲基- D -葡胺, ReagentPlus®, ≥99.0% (T)
Sigma-Aldrich
葡甲胺, 99.0-100.5% dry basis, meets USP testing specifications
Supelco
胆影葡胺, Pharmaceutical Secondary Standard; Certified Reference Material
胆影葡胺, European Pharmacopoeia (EP) Reference Standard